Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment
Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.